检索

期
标题
作者
卷 86, 编号 3 (2014)
Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease
Akhmineeva A.
卷 88, 编号 2 (2016)
Evaluation of cardiovascular remodeling and epicardial fat thickness in patients with chronic heart failure and metabolic syndrome
Drapkina O., Zyatenkova E.
PDF
(Rus)
卷 90, 编号 8 (2018)
Efficiency of vaccine prophylaxis concentrated pneumococcal vaccine in patients with chronic obstructive lung disease and chronic heart failure
Ignatova G., Antonov V.
PDF
(Rus)
卷 85, 编号 8 (2013)
The combined drug ascoril in the treatment of patients with chronic obstructive pulmonary disease concurrent with coronary heart disease
Grigor'eva N., Kuznetsov A., Koroleva T., Koroleva M.
卷 95, 编号 9 (2023)
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O., Komarov A., Krivosheeva E., Dobrovolsky A., Titaeva E., Amelyushkina V., Gomyranova N., Panchenko E.
PDF
(Rus)
卷 86, 编号 9 (2014)
A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease
Galeeva Z., Galiavich A.
卷 83, 编号 1 (2011)
Some problems of pathogenesis and clinical symptoms of atherosclerosis (coronary heart disease, hypertension) in the Far North
Tikhonov D., Nikolaev V., Sedalishchev V., Tikhonov D., Nikolaev V., Sedalischev V.
卷 95, 编号 8 (2023)
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E., Vaizova O., Meleshko M., Samoilova I., Podchinenova D., Borozinets A., Matveeva M., Kudlay D.
PDF
(Rus)
卷 92, 编号 3 (2020)
Cardiovascular and chronic obstructive pulmonary diseases: pathophysiological processes and treatment tactics
Ambatiello L., Chazova I.
PDF
(Rus)
卷 91, 编号 1 (2019)
Comorbidity and polymorbidity of the patient with chronic obstructive pulmonary disease and cardiovascular diseases
Grigoryeva N., Maiorova M., Korolyova M., Samolyuk M.
PDF
(Rus)
卷 86, 编号 1 (2014)
The course of coronary heart disease concurrent with peptic ulcer disease: Clinical and pathogenetic aspects
Simonova Z., Martusevich A., Tarlovskaia E.
卷 82, 编号 3 (2010)
Aortic stiffness in chronic obstructive pulmonary disease concurrent with coronary heart disease
Nevzorova V., Shekunova O., Brodskaya T., Nevzorova V., Shekunova O., Brodskaya T.
卷 80, 编号 8 (2008)
Beta-adrenoblockers use in combination of cardiovascular and pulmonary diseases
Makolkin V., Ovcharenko S., Litvinova I.
卷 82, 编号 2 (2010)
Digestive system pathology in patients with chronic obstructive pulmonary disease concurrent with coronary heart disease
Shoykhet Y., Klester E., Shoikhet Y., Klester E.
卷 85, 编号 8 (2013)
Chronic obstructive pulmonary disease and comorbidities
Chuchalin A.
卷 79, 编号 3 (2004)
Clinicohemodynamic efficacy of a selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease
Fedorova Т., Ilyina Y., Sotnikova Т., Rybakova M., Loschits N.
卷 88, 编号 9 (2016)
Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure
Teplyakov A., Berezikova E., Shilov S., Grakova E., Torim Y., Efremov A., Popova A., Pustovetova M., Sabirova A., Kopyeva K.
PDF
(Rus)
卷 85, 编号 1 (2013)
Impact of angiotensionogen and angiotensin II receptor type 1 gene polymorphisms on the development and course of chronic heart failure
Tepliakov A., Shilov S., Berezikova E., Efremov A., Safronov I., Pustovetova M., Maianskaia S., Torim I., Karpov R.
卷 78, 编号 9 (2003)
Effects of trimetazidine and perindopril on myocardialfunction and metabolism in postmyocardial infarction patients with cardiac failure
Shabrov A., Arkharov I., Burbello А., Makhnov A.
卷 91, 编号 8 (2019)
Evaluation of the efficiency of combined pharmacotherapy with the use of trimetazidine with prolonged release in patients with stable angina in outpatient practice
Luneva Y., Povetkin S.
PDF
(Rus)
卷 93, 编号 12 (2021)
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
Arutyunov G., Lopatin Y., Ametov A., Ageev F., Antsiferov M., Villevalde S., Vinogradova N., Galstyan G., Galyavich A., Gilyarevskiy S., Glezer M., Zhirov I., Ilyin M., Lebedeva A., Nedogoda S., Salukhov V., Tarlovskaya E., Tereshchenko S., Fomin I., Khalimov I., Khasanov N., Cherkashin D., Yakushin S.
PDF
(Rus)
卷 84, 编号 5 (2012)
MULTISLICE COMPUTED TOMOANGIOGRAPHY IN ASSESSMENT OF CORONARY STENT LUMEN
Arkhipova I., Sinitsyn V.
卷 87, 编号 4 (2015)
Assessment of the role of matrix metalloproteinase-2 gene polymorphism in the development of chronic heart failure
Teplyakov A., Berezikova E., Shilov S., Grakova E., Torim Y., Efremov A., Safronov I., Pustovetova M., Karpov R.
卷 96, 编号 4 (2024): Issues of diagnostics of internal diseases
Detection of left ventricular systolic dysfunction in patients with ischemic heart disease using spatial and frontal QRS-T angles of the electrocardiogram
Sakhnova T., Blinova E., Dotsenko Y., Uskach T., Drozdov D.
PDF
(Rus)
卷 81, 编号 1 (2009)
Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of acute coronary syndrome and in transcutaneous coronary interventions
Fettser D., Preobrazhenskiy D., Batyraliev T., Sidorenko B., Aytach V., Fettser D., Preobrazhensky D., Batyraliev T., Sidorenko B., Aitach V.
卷 89, 编号 5 (2017)
Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy
Muslimova E., Afanasiev S., Rebrova T., Sergienko T., Repin A.
PDF
(Rus)
卷 86, 编号 10 (2014)
Comparative characteristics of carotid atherosclerosis in patients with hypertension concurrent with chronic coronary heart disease among the indigenous and non-indigenous population of the Yamal-Nenets Autonomic District
Gapon L., Sereda T., Leont'eva A., Gul'tiaeva E.
卷 86, 编号 3 (2014)
The features of risk factors, systemic inflammation, and endothelial dysfunction in patients with asthma concurrent with coronary heart disease
Belan O., Kaĭdashev I., Borzykh O.
卷 84, 编号 4 (2012)
THE ROLE OF DUPLEX SCANNING OF THE CAROTID ARTERIES IN DETECTION OF CORRELATIONS BETWEEN CAROTID AND CORONARY ATHEROSCLEROSIS BY THE RESULTS OF CORONAROANGIOGRAPHY IN PATIENTS WITH STABLE ANGINA
Gaisenok O., Martsevich S., Kalashnikov S., Boshkov V., Shatalova I.
卷 82, 编号 12 (2010)
New aspects of using dihydropyridine calcium antagonists during coronary bypass surgery
Vecherskiy Y., Andreev S., Murashev B., Vechersky Y., Andreyev S., Murashev B.
卷 82, 编号 4 (2010)
Value of exercise electrocardiography and other current instrumental studies in the evaluation of percutaneous coronary interventions and in the detection of restenosis
Lupanov V., Lupanov V.
卷 78, 编号 4 (2003)
Clinical perspectives of using scintigraphy with 123-1-MIBG for assessment of sympathetic nervous system of the myocardium
Sergienko I., Naumov V., Samoilenko L., Burgalova M., Sergienko V.
卷 93, 编号 1 (2021)
Prevalence of ischemic heart disease depending on factors of psychoemotional stress among men of mature age (epidemiological study)
Akimova E., Akimov M., Kayumova M., Gafarov V.
PDF
(Rus)
卷 91, 编号 12 (2019)
Peculiarities of heart risk in patients with non - alcoholic fatial liver disease
Mosina L., Stolyarova V., Esina M., Titojkina Y., Korobkov D.
PDF
(Rus)
卷 91, 编号 9 (2019)
Cardiogenic shock in patients with acute coronary syndrome (data from Russian Federal Acute Coronary Syndrome Registry)
Sagaydak O., Oschepkova E., Chazova I.
PDF
(Rus)
卷 87, 编号 1 (2015)
Identification of circulatory diseases and their risk during medical examination of an adult population: Methodological aspects
Kalinina A., Ipatov P., Kaminskaia A., Kushunina D.
卷 85, 编号 1 (2013)
Multislice spiral computed tomography of coronary arteries: procedure development stages and clinical application
Likov I., Morozov S.
卷 84, 编号 1 (2012)
Effects of anomalous rise of air temperature on population mortality
Chazov E., Boytsov S., Chazov E., Boitsov S.
卷 82, 编号 8 (2010)
Implantation of the paclitaxel-eluting stent Apollo in patients with stable angina pectoris: Long-term angiographic and clinical results
Batyraliev T., Fetser D., Samko A., Sidorenko B.
卷 79, 编号 10 (2004)
ACE inhibitors in the treatment of ischemicheart disease and prevention of its complications (review)
Schekotov V.
卷 78, 编号 12 (2003)
The state of theleft ventricle of the heart and 24-h profile of arterial pressure in patients with effort angina and episodes of painlessmyocardial ischemia
Mazur E., Mazur V., Tkhind В., Omar I.
卷 93, 编号 1 (2021)
Telomere length as a biomarker of the risk of cardiovascular complications in patients with coronary heart disease
Doroshchuk N., Lankin V., Tikhaze A., Kheimets G., Doroshсhuk A., Smirnova M., Chazova I.
PDF
(Rus)
卷 82, 编号 1 (2010)
Role of a local therapeutic service in the timely identification, treatment, and rehabilitation of patients with coronary heart disease
Korzhenkov N., Kuzichkina S., Shcherbakova N., Korzhenkov N., Kuzichkina S., Shcherbakova N.
卷 89, 编号 12 (2017)
A retrospective historical study evaluating the safe use of current antidepressants in cardiology practice
Ivanov S., Volel B., Syrkina E., Ternovaya E., Troshina D., Grubova M., Tolkacheva I., Rozhkov A., Simonov A.
PDF
(Rus)
卷 89, 编号 4 (2017)
Structural features of the lipid bilayer of the red blood cell membrane in people with isolated hypercholesterolemia without coronary artery disease and in patients with coronary artery disease
Vasilev A., Streltsova N., Lystsova N.
PDF
(Rus)
卷 86, 编号 6 (2014)
The current diagnosis and clinical prognostic value of kidney dysfunction in patients with coronary heart disease
Shafranskaia K., Bykova I.
卷 80, 编号 12 (2008)
Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction
Kremneva L., Shalaev S., Kremneva L., Shalaev S.
卷 79, 编号 8 (2004)
The problem ofpreventing vascular restenosis after implantation of a coronary stent
Sumarokov А., Samko A., Naumov V.
卷 79, 编号 4 (2004)
Exercise and nicotinic acid delayed action drug - enduracin: application in outpatient rehabilitation of patients with ischemic heart disease
Oganov R., Aronov D., Krasnitsky V., Perova N., Olferyev A., Smolensky A., Novikova N., Vygodin V.
卷 79, 编号 3 (2004)
Obstructive sleep apnoea and cardiac arrythmia
Belov A., Zakharov V., Gorenkova M., Voronin I.
1 - 50 的 91 信息 1 2 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语